Cures Conversation: Where rare diseases overlap, new treatments might exist

L2C Founder, Anna Greka, joined Becky Quick on CNBC Cures to spotlight how L2C is reshaping rare disease drug development. In their conversation, Anna breaks down how nodal biology uncovers shared pathways across rare conditions, unlocking scalable, sustainable treatments for underserved patient communities.